联合王国正在试验一项新的血检,用于对阿尔茨海默氏病的诊断,测量蛋白质p-tau217。 A new blood test for Alzheimer's diagnosis, measuring protein p-tau217, is being trialed in the UK.

英国病人正在参加新的验血试验 以改变阿尔茨海默氏病的诊断结果 British patients are participating in a trial for a new blood test that could revolutionize Alzheimer's diagnosis. 伦敦大学学院正在对测量蛋白质p-tau217的测试进行调查,以改进早期和准确的诊断。 The test, measuring protein p-tau217, is being investigated by University College London to improve early and accurate diagnosis. 这项研究由 " 血液生物标志挑战 " (一个数百万磅的方案)资助,旨在征聘1 100名不同的参与者,以确保广泛适用。 Funded by the Blood Biomarker Challenge, a multimillion-pound program, the study aims to recruit 1,100 diverse participants to ensure wide applicability. 如果成功,血液检测可以与其他方法一起使用,在有记忆问题的患者中诊断阿尔茨海默氏病。 If successful, blood tests could be used alongside other methods to diagnose Alzheimer's in patients with memory issues.